Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily

Blueprint Medicines (BPMC) Financial Statements

541 Followers

Blueprint Medicines Financial Overview

Blueprint Medicines's market cap is currently ―. The company's EPS TTM is $-2.107; its P/E ratio is -43.03; Blueprint Medicines is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 128.18M$ 138.16M$ 96.12M$ 71.96M$ 56.57M
Gross Profit$ 126.25M$ 130.56M$ 92.92M$ 71.70M$ 53.78M
EBIT$ -56.00M$ -49.89M$ 104.39M$ -123.46M$ -129.71M
EBITDA$ -49.62M$ -43.82M$ 109.20M$ -121.93M$ -124.53M
Net Income Common Stockholders$ -56.28M$ -49.99M$ 89.14M$ -110.92M$ -130.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 734.17M$ 763.60M$ 647.90M$ 710.64M$ 712.98M
Total Assets$ 1.20B$ 1.20B$ 1.04B$ 1.05B$ 1.11B
Total Debt$ 732.70M$ 740.35M$ 597.93M$ 774.12M$ 774.18M
Net Debt$ -1.47M$ -23.25M$ -49.97M$ 63.48M$ 61.19M
Total Liabilities$ 886.50M$ 883.32M$ 727.79M$ 918.64M$ 902.69M
Stockholders Equity$ 313.15M$ 320.24M$ 310.69M$ 130.61M$ 202.61M
Cash Flow-
Free Cash Flow$ -13.66M$ -50.64M$ -102.62M$ -83.60M$ -110.73M
Operating Cash Flow$ -13.64M$ -48.07M$ -101.51M$ -78.93M$ -104.48M
Investing Cash Flow$ 29.95M$ -188.29M$ 77.13M$ 78.77M$ -9.59M
Financing Cash Flow$ 18.38M$ 178.01M$ 66.96M$ 15.53M$ 98.40M
Currency in USD

Blueprint Medicines Earnings and Revenue History

Blueprint Medicines Debt to Assets

Blueprint Medicines Cash Flow

Blueprint Medicines Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis